# Research gaps and unmet challenges to study the impact of chemicals on neurodegenerative diseases

Cécilia Samieri, Sophie Lefèvre-Arbogast, Jade Chaker, Fabien Mercier, Robert Barouki, Xavier Coumoul, Gary Miller, Arthur David

► To cite this version:

Cécilia Samieri, Sophie Lefèvre-Arbogast, Jade Chaker, Fabien Mercier, Robert Barouki, et al. Research gaps and unmet challenges to study the impact of chemicals on neurodegenerative diseases. Alzheimer's Association International Conference, Alzheimer's Association, Jul 2024, Pennsylvania, France. pp.e087446, 10.1002/alz.087446. hal-04893463

HAL Id: hal-04893463

https://hal.science/hal-04893463v1

Submitted on 17 Jan 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
EPIDEMIOLOGY

Research gaps and unmet challenges to study the impact of
chemicals on neurodegenerative diseases

Cécilia Samieri<fnref n="1" /> | Sophie Lefèvre-Arbogast<fnref n="1" /> | Jade Chaker<fnref n="2" /> | Fabien Mercier<fnref n="2" /> |
Robert Barouki<fnref n="3" /> | Xavier Coumoul<fnref n="3" /> | Gary W Miller<fnref n="4" /> | Arthur David<fnref n="2" />

Correspondence

Cécilia Samieri, Bordeaux Population Health Research Center, Inserm U1219, University of Bordeaux, Bordeaux, France.

Email: cecilia.samieri@u-bordeaux.fr

Abstract

Chemicals are ubiquitous in modern life. More than 100,000 chemicals are currently used worldwide, and the production continues to increase. Measuring with accuracy all the components of the chemical exposome represents a tremendous challenge which has been only very partly met so far, and gaps in science remain multiple. For example, there is a need for a comprehensive understanding of the chemical exposome's impact on the brain, emphasizing the integration of various exposure routes and an expanded list of emerging concern chemicals. Biomonitoring, a relatively recent approach, has begun linking internal exposure to neurological impacts, shedding light on the potential neurotoxicity of non-persistent pesticides like neonicotinoids and pyrethroids. Research should explore overlooked ubiquitous chemicals, such as flame retardants, fluorosurfactants, plasticizers, and food additives, and overlooked pathways such as neurovascular dysfunction or the impact on non-neuronal cells. Furthermore, analytical challenges posed by exposomic studies are specifically important, since the chemical space is highly variable, dynamic and diverse in concentration levels (with ultra-trace substances). Chemical exposures are multiple and potential additive or synergistic effects of chemicals, within mixtures, likely underlie the impact of the chemical exposome on the brain. Capturing the depth and breadth of that chemical exposome necessitates cutting-edge molecular markers. The development of high throughput omics-based molecular approaches has allowed simultaneous analysis of thousands of individual biological entities at a large scale – a technological revolution which has enabled the development of exposomics. High-resolution mass spectrometry (HRMS)-based methods applied to various matrices, allows to uncover unknown elements of the internal chemical exposome associated with neurodegenerative diseases.

This presentation will discuss all the promises that new technologies combined with omics-based methodologies could provide to uncover unknown chemical signatures associated to neurodegenerative diseases.

This is an open access article under the terms of the [Creative Commons Attribution License](https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

© 2024 The Alzheimer's Association. *Alzheimer's & Dementia* published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

<footnote n="1">¹Bordeaux Population Health Research Center, Inserm U1219, University of Bordeaux, Bordeaux, France</footnote>

<footnote n="2">²Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), Rennes, NA, France</footnote>

<footnote n="3">³Université Paris Cité, T3S, INSERM UMR-S 1124, Paris, NA, France</footnote>

<footnote n="4">⁴Mailman School of Public Health, Columbia University, New York, NY, USA</footnote>